Maspin expression has also been observed to be upregulated in pancreatic, gallbladder, and thyroid cancers [33–35] but down-regulated in breast, prostate, and gastric cancers and melanomas [33–35]. This evidence concerns the gene SERPINB5 and thyroid cancer.